Dialysis independence following single-agent daratumumab in refractory myeloma with renal failure

Ir J Med Sci. 2019 Aug;188(3):1079-1080. doi: 10.1007/s11845-018-1951-6. Epub 2018 Dec 19.

Authors

Elizabeth Smyth¹, Siobhan Glavey¹, Dario Melotti¹, Patrick Thornton¹, Jeremy Sargent¹, Peter Conlon², Philip Murphy¹, John Quinn³

Affiliations

¹ Department of Haematology, Beaumont Hospital, Dublin 9, Beaumont, Ireland.
² Department of Nephrology, Beaumont Hospital, Dublin 9, Beaumont, Ireland.
³ Department of Haematology, Beaumont Hospital, Dublin 9, Beaumont, Ireland. [email protected].

PMID: 30569372
DOI: 10.1007/s11845-018-1951-6

No abstract available

Keywords: Daratumumab; Dialysis independence; Dialysis-dependant renal failure; Multiple myeloma.

Publication types

Letter